 |
| FAQ/Help |
| Calendar |
| Search |
|
#1
Sep 11, 2014, 09:44 AM
|
||||
|
||||
|
Small Molecules Help Reactivate Receptor Linked With Schizophrenia | Chemical & Engineering News
All the current meds target dopamine and thus only positive symptoms but this one targets glutamate and thus both.....it's very specific and based on actual human mutations and thus will only work for a subset of individuals.....it's currently being tested in rats.....let's hope the drug companies pick this one up. The target is GRM1 and it activates rather than inhibits the receptor....
__________________
Hugs! 
|
 Atypical_Disaster, Axiom, Loial
|
|
#2
Sep 11, 2014, 09:46 AM
|
||||
|
||||
|
This post has been brought to you by the letter Q and you're watching the thanks for sharing network.....seriously no one is going to comment on this but I thought it was cool and hopeful....
__________________
Hugs!
|
| Atypical_Disaster, Erti, junkDNA, medicalfox
|
|
#3
Sep 11, 2014, 10:21 AM
|
||||
|
||||
|
Quote:
|
| Sometimes psychotic
|
|
#4
Sep 11, 2014, 02:45 PM
|
|||
|
|||
|
Thanks for sharing!
No seriously, I appreciate you keeping us up to date with the research. If it's a small subsection though, there might not be a big enough potential profit to make it worth a drug company's expense to bring to market :/ Quote:
 *Willow* |
| Sometimes psychotic
|
| Reply |
This is an old thread. You probably should not post your reply to it, as the original poster is unlikely to see it.|
|
My Support Forums is the online community that was originally begun as the Psych Central Forums in 2001. It now runs as an independent self-help support group community for mental health, personality, and psychological issues and is overseen by a group of dedicated, caring volunteers from around the world.
Linear Mode
